Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria V Lane"'
Autor:
David M Barrett, Daniel Martinez, Tiffany Smith, Jessica B Foster, Crystal Griffin, Jo Lynne Rokita, Allison Stern, Cameron Brimley, Komal Rathi, Maria V Lane, Samantha N Buongervino, Peter J Madsen, Alberto Delaidelli, Poul H Sorensen, Robert J Wechsler-Reya, Katalin Karikó, Phillip B Storm, Adam C Resnick, John M Maris, Kristopher R Bosse
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)
Background Pediatric brain tumors are the leading cause of cancer death in children with an urgent need for innovative therapies. Glypican 2 (GPC2) is a cell surface oncoprotein expressed in neuroblastoma for which targeted immunotherapies have been
Externí odkaz:
https://doaj.org/article/e7606fcfe47343a78a08e0f4943daef3
Autor:
Yael P. Mossé, John M. Maris, Geoffrey R. Oxnard, Marni Brisson Tierno, Marilyn M. Li, Matthew L. Margolis, Xin Liu, Megan Friedrichsen, Jennifer Stundon, Alexander A. Daniels, Esther R. Berko, Jennifer Saggio, Maria Gemino-Borromeo, Adam Hyman, Alana Fitzsimmons, Sriyaa Suresh, Samantha N. Buongervino, Guillem Pascual-Pasto, Patrick M. Schürch, Brendan McIntyre, Maria V. Lane, Anna Maria Giudice, Kristopher R. Bosse
Supplementary Data from Serial Profiling of Circulating Tumor DNA Identifies Dynamic Evolution of Clinically Actionable Genomic Alterations in High-Risk Neuroblastoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27d61f8b32d4c4f1b5a8baa78624d428
https://doi.org/10.1158/2159-8290.22541887
https://doi.org/10.1158/2159-8290.22541887
Autor:
Jessica B Foster, Crystal Griffin, Jo Lynne Rokita, Allison Stern, Cameron Brimley, Komal Rathi, Maria V Lane, Samantha N Buongervino, Tiffany Smith, Peter J Madsen, Daniel Martinez, Alberto Delaidelli, Poul H Sorensen, Robert J Wechsler-Reya, Katalin Karikó, Phillip B Storm, David M Barrett, Adam C Resnick, John M Maris, Kristopher R Bosse
Publikováno v:
Journal for immunotherapy of cancer. 10(9)
BackgroundPediatric brain tumors are the leading cause of cancer death in children with an urgent need for innovative therapies. Glypican 2 (GPC2) is a cell surface oncoprotein expressed in neuroblastoma for which targeted immunotherapies have been d
Autor:
Kristopher R. Bosse, Anna Maria Giudice, Maria V. Lane, Brendan McIntyre, Patrick M. Schürch, Guillem Pascual-Pasto, Samantha N. Buongervino, Sriyaa Suresh, Alana Fitzsimmons, Adam Hyman, Maria Gemino-Borromeo, Jennifer Saggio, Esther R. Berko, Alexander A. Daniels, Jennifer Stundon, Megan Friedrichsen, Xin Liu, Matthew L. Margolis, Marilyn M. Li, Marni Brisson Tierno, Geoffrey R. Oxnard, John M. Maris, Yael P. Mossé
Publikováno v:
Cancer discovery. 12(12)
Neuroblastoma evolution, heterogeneity, and resistance remain inadequately defined, suggesting a role for circulating tumor DNA (ctDNA) sequencing. To define the utility of ctDNA profiling in neuroblastoma, 167 blood samples from 48 high-risk patient